Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathological study.
Journal
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040
Informations de publication
Date de publication:
20 Mar 2023
20 Mar 2023
Historique:
pubmed:
1
12
2022
medline:
22
3
2023
entrez:
30
11
2022
Statut:
ppublish
Résumé
Recent clinical studies are testing strategies for short (1-3 months) dual antiplatelet therapy following newer-generation drug-eluting stent (DES) placement. However, detailed biological responses to newer-generation DES remain unknown in humans. We sought to evaluate early pathologic responses to abluminal biodegradable polymer-coated (BP-) DES compared with circumferential durable polymer-coated (DP-) DES in human autopsy cases. The study included 38 coronary lesions with newer-generation DES implanted for <90 days (DP-DES=24, BP-DES=14) in 26 autopsy cases. The degree of strut coverage was defined as follows: grade 0 (bare), grade 1 (with fibrin or tissues/cells without endothelium), grade 2 (with single-layered endothelium), and grade 3 (with endothelium and underlying smooth muscle cell layers). The duration following implantation was similar in DP- and BP-DES (median=20 vs 17 days). A total of 2,022 struts (DP-DES=1,297, BP-DES=725) were pathologically analysed. Focal grade 2 coverage was observed as early as 5 days after the implantation in both stents. The multilevel mixed-effects ordered logistic regression model demonstrated that BP-DES exhibited greater strut coverage compared with DP-DES (odds ratio [OR]: 3.64, 95% confidence interval [CI]: 1.37-9.67; p=0.009), which remained significant after adjustment for the duration following implantation and underlying tissue characteristics (OR: 2.74, 95% CI: 1.10-6.80; p=0.030). The predictive probability of grade 2 and 3 coverage was comparably limited at 30 days (DP-DES=17.1%, BP-DES=28.7%) and increased at 90 days (DP-DES=76.5%, BP-DES=86.6%). Both stents showed low inflammation and a similar degree of fibrin deposition. Single-layered endothelial coverage begins in the days after newer-generation DES placement, and BP-DES potentially exhibit faster strut coverage with smooth muscle cell infiltration than DP-DES in humans. Nevertheless, vessel healing remains suboptimal in both stents at 30 days.
Sections du résumé
BACKGROUND
BACKGROUND
Recent clinical studies are testing strategies for short (1-3 months) dual antiplatelet therapy following newer-generation drug-eluting stent (DES) placement. However, detailed biological responses to newer-generation DES remain unknown in humans.
AIMS
OBJECTIVE
We sought to evaluate early pathologic responses to abluminal biodegradable polymer-coated (BP-) DES compared with circumferential durable polymer-coated (DP-) DES in human autopsy cases.
METHODS
METHODS
The study included 38 coronary lesions with newer-generation DES implanted for <90 days (DP-DES=24, BP-DES=14) in 26 autopsy cases. The degree of strut coverage was defined as follows: grade 0 (bare), grade 1 (with fibrin or tissues/cells without endothelium), grade 2 (with single-layered endothelium), and grade 3 (with endothelium and underlying smooth muscle cell layers).
RESULTS
RESULTS
The duration following implantation was similar in DP- and BP-DES (median=20 vs 17 days). A total of 2,022 struts (DP-DES=1,297, BP-DES=725) were pathologically analysed. Focal grade 2 coverage was observed as early as 5 days after the implantation in both stents. The multilevel mixed-effects ordered logistic regression model demonstrated that BP-DES exhibited greater strut coverage compared with DP-DES (odds ratio [OR]: 3.64, 95% confidence interval [CI]: 1.37-9.67; p=0.009), which remained significant after adjustment for the duration following implantation and underlying tissue characteristics (OR: 2.74, 95% CI: 1.10-6.80; p=0.030). The predictive probability of grade 2 and 3 coverage was comparably limited at 30 days (DP-DES=17.1%, BP-DES=28.7%) and increased at 90 days (DP-DES=76.5%, BP-DES=86.6%). Both stents showed low inflammation and a similar degree of fibrin deposition.
CONCLUSIONS
CONCLUSIONS
Single-layered endothelial coverage begins in the days after newer-generation DES placement, and BP-DES potentially exhibit faster strut coverage with smooth muscle cell infiltration than DP-DES in humans. Nevertheless, vessel healing remains suboptimal in both stents at 30 days.
Identifiants
pubmed: 36448921
pii: EIJ-D-22-00650
doi: 10.4244/EIJ-D-22-00650
pmc: PMC10018292
pii:
doi:
Substances chimiques
Polymers
0
Fibrin
9001-31-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1284-1294Références
Int J Cardiol. 2021 Sep 1;338:42-49
pubmed: 34174338
N Engl J Med. 2019 Nov 21;381(21):2032-2042
pubmed: 31556978
Circ J. 2018 Sep 25;82(10):2594-2601
pubmed: 29998921
J Long Term Eff Med Implants. 2000;10(1-2):143-51
pubmed: 10947627
Nat Rev Cardiol. 2012 May 22;9(8):439-53
pubmed: 22614618
Nat Rev Cardiol. 2020 Jan;17(1):37-51
pubmed: 31346257
Cardiovasc Interv Ther. 2019 Jan;34(1):14-24
pubmed: 29318464
Circ Cardiovasc Interv. 2020 May;13(5):e008869
pubmed: 32338525
JACC Cardiovasc Interv. 2017 Dec 11;10(23):2375-2387
pubmed: 29102583
Lancet. 2018 Mar 31;391(10127):1274-1284
pubmed: 29544699
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1248-1260
pubmed: 26292590
Circulation. 2001 Jul 24;104(4):473-9
pubmed: 11468212
JAMA Cardiol. 2022 Apr 01;7(4):407-417
pubmed: 35234821
Circulation. 2007 May 8;115(18):2435-41
pubmed: 17438147
N Engl J Med. 2021 Oct 28;385(18):1643-1655
pubmed: 34449185
Nat Rev Cardiol. 2016 Feb;13(2):79-98
pubmed: 26503410
J Am Heart Assoc. 2016 Oct 19;5(10):
pubmed: 27792651
Heart. 2003 Feb;89(2):133-8
pubmed: 12527658
Circulation. 2014 Jan 14;129(2):211-23
pubmed: 24163064
JAMA. 2019 Jun 25;321(24):2414-2427
pubmed: 31237644